Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-22

Clinical Trial Update: Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of sunitinib in women with advanced breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sutent (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2011-07-22